The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...

Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has continued to show impressive results in clinical trial, with an update at the EHA congress showing long-term effects on ...

Bayer has bolstered its cell and gene therapy platform by securing access to a CRISPR-based gene-editing platform developed by US biotech Mammoth Biosciences. The German group is paying $40 ...

The kit utilizes Illumina-compatible adapter sequences and has been validated on Illumina platforms. Main Features Input as low as 60 fresh cells (400 pg DNA). Around 100-300 FFPE cells (660-1980 pg).

High quality WTA products produce three PCR amplicons of 489, 378, and 290 base pairs, as seen in the image below showing Ampli1™ WTA QC Kit analysis of single A549 cell transcriptomes amplified ...

But modifying biology is inherently risky. With CRISPR kits now available for sale on the internet, anyone with some degree of biological knowledge could potentially create and release a new living ...